Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,736 | 3,778 | 4,824 | 5,961 | 6,799 |
| Other current assets | 147 | 147 | 150 | 216 | 323 |
| TOTAL | $8,024 | $4,107 | $5,093 | $6,307 | $7,243 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 11 | 0 | 26 | 0 |
| TOTAL | $N/A | $11 | $N/A | $26 | $N/A |
| Total Assets | $8,024 | $4,118 | $5,093 | $6,334 | $7,243 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 373 | 370 | 226 | 232 | 162 |
| Other current liabilities | 159 | 275 | 77 | 27 | 214 |
| TOTAL | $532 | $645 | $303 | $259 | $376 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $532 | $645 | $303 | $259 | $376 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,665 | 1,665 | 1,375 | 1,375 | 1,375 |
| Common Shares | 2 | 1 | 1 | 1 | 1 |
| Retained earnings | -40,285 | -38,739 | -37,082 | -35,053 | -33,814 |
| TOTAL | $7,492 | $3,473 | $4,790 | $6,075 | $6,866 |
| Total Liabilities And Equity | $8,024 | $4,118 | $5,093 | $6,334 | $7,243 |